Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2806 - Cumulative EQD<sub>2</sub> Dose Reporting from an Adaptive Reirradiation Phase I Trial of Ablative 5-Fraction Stereotactic MR-Guided Radiotherapy for Abdominal and Pelvic Tumors
Presenter(s)
Kathryn Mittauer, PhD - Miami Cancer Institute- Baptist Health South Florida, Miami, FL